Diabeloop develops disruptive technological innovations for diabetes treatment.
Originating from a French artificial pancreas research program, the DBLG1™ System is a self-learning device that embeds AI to better serve patients.
DGLB1™ System is an external medical device that connects 3 components: a continuous glucose monitor (CGM), a patch insulin pump and a locked-down handset hosting Diabeloop algorithm and user interface.
How does it work? Every 5 minutes, a glucose measurement is transmitted via Bluetooth technology to the handset. DBLG1 artificial intelligence analyzes data in real time and takes into account the patient’s physiology, history and data entries (meals or exercise) to determine the correct dose of insulin to administer. That’s what we call a hybrid closed-loop system.
Diabeloop DBLG1™ is a medical device for the treatment of Type 1 diabetes in adults. This device is intended for single patient use and requires a prescription. For full indications for use and safety information see user manual. All content and information provided by this website is intended as informative and can not serve as a substitute for a health professional’s advice, diagnosis or prescription. All decisions related to your therapy and treatment should be discussed with your doctor.
DBLG1™ has received CE marking.